GlycoMimetics, Inc.
General ticker "GLYC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $16.1M (TTM average)
GlycoMimetics, Inc. follows the US Stock Market performance with the rate: 21.6%.
Estimated limits based on current volatility of 10.4%: low 15.51$, high 19.11$
Factors to consider:
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.67$, 24.26$]
- 2025-12-31 to 2026-12-31 estimated range: [8.55$, 22.87$]
Financial Metrics affecting the GLYC estimates:
- Negative: Non-GAAP EPS, $ of -0.59 <= 0.05
- Negative: Operating cash flow per share per price, % of -1.74 <= 1.99
- Negative: negative Net income
- Negative: Operating profit margin, % of -100 <= 0.04
- Negative: Industry operating profit margin (median), % of -98.39 <= 0.07
- Negative: Industry earnings per price (median), % of -24.73 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -20.97 <= 2.94
Short-term GLYC quotes
Long-term GLYC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.07MM | $0.01MM | $0.00MM |
| Operating Expenses | $47.48MM | $39.29MM | $40.04MM |
| Operating Income | $-47.40MM | $-39.28MM | $-40.04MM |
| Non-Operating Income | $0.71MM | $2.38MM | $2.16MM |
| R&D Expense | $28.39MM | $20.07MM | $14.26MM |
| Income(Loss) | $-46.69MM | $-36.90MM | $-37.88MM |
| Taxes | $46.64MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-93.33MM | $-36.90MM | $-37.88MM |
| Stockholders Equity | $42.93MM | $38.41MM | $5.31MM |
| Assets | $51.81MM | $45.32MM | $11.09MM |
| Operating Cash Flow | $-46.46MM | $-34.88MM | $-31.10MM |
| Capital expenditure | $0.08MM | $0.02MM | $0.01MM |
| Investing Cash Flow | $-0.08MM | $-0.02MM | $0.02MM |
| Financing Cash Flow | $4.16MM | $28.82MM | $0.01MM |
| Earnings Per Share** | $-1.78 | $-0.58 | $-0.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.